[Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia].
Pivnik
A V
AV
Shtroiakovskiĭ
D L
DL
Medvedev
P V
PV
Moiseeva
T N
TN
Shklovskiĭ-Kordi
N E
NE
Skorokhod
A A
AA
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003630:Daunorubicin / Q000008:administration & dosage* / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008081:Liposomes; D012008:Recurrence; D013997:Time Factors; D014212:Tretinoin / Q000008:administration & dosage
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D008081:Liposomes; D014212:Tretinoin; D003630:Daunorubicin